Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs? . (2011). Clinics, 66(7), 1171-1175. https://doi.org/10.1590/S1807-59322011000700008